Sartorius, an international pharmaceutical and laboratory equipment supplier, has opened a new state-of-the-art manufacturing facility in Havant.
The opening by Alan Mak, MP for Havant, marked the official relocation of more than 90 employees to the new facility, located just a few miles away from the former site in Portsmouth.
“The new facility in Havant will be an important part of our global operations network as it will enable our business to grow to meet the requirements of the expanding industry,” said Dr. Thorsten Peuker, Head of Operations, BPS Systems at Sartorius.
The 58,000-square-foot will bring together skilled engineers with biochemical, electrical, and mechanical backgrounds who will design and manufacture a range of systems for the biopharmaceutical market, including chromatography columns and time- and cost-saving filtration systems. These systems are crucial for manufacturing injectable drugs used to treat cancer and diabetes and for producing vaccines to prevent the spread of viruses.
In addition to a 28,000-square-foot production area, the centre accommodates a 4,000-square-foot customer test lab to demonstrate the functionality of Sartorius equipment.
In 2021, Sartorius will invest more than 400 million euros in the expansion of manufacturing capacities around the world to meet the high demand from the growing biopharmaceuticals market. In line with these investments, Sartorius aims to expand the Havant site, and the company is now offering positions for process engineers, project managers, and design engineers, as well as for several support functions, among other job vacancies. With its new facility in Havant, Sartorius now has five locations in the UK, employing over 900 staff members.